Showing 321-330 of 333 grants
Title | Institution | Researcher | Program | Duration | Total Award Amount |
---|---|---|---|---|---|
Clinical Trial of Denosumab for Type 1 Diabetes | Beckman Research Institute of the City of Hope | Rupangi Vasavada | Cures | 01-October-2023 to 30-September-2026 | $2,232,400.00 |
A novel approach to overcome innate immunity in beta-cell replacement therapy for type 1 diabetes | Baylor Research Institute | Bashoo Naziruddin | Cures | 01-January-2025 to 31-December-2027 | $749,769.68 |
Understanding Disease Mechanisms Underlying Type 1 Diabetes | Baylor College of Medicine | Ashok Balasubramanyam | Cures | 01-November-2024 to 31-October-2027 | $967,091.04 |
Unraveling the Influence of Obesity on Progression Along Preclinical Stages of Type 1 Diabetes | Baylor College of Medicine | Maria Redondo | Cures | 01-June-2025 to 31-May-2028 | $1,124,188.00 |
Avera eCare School Health T1D Demonstration Project | Avera McKennan | Christine Hockett | Improving Lives | 01-November-2021 to 31-July-2025 | $4,000,979.73 |
Oxygen Enabled High-capacity Vascularized Devices for ß-cell Replacement Therapy in Humans | Arizona Board of Regents, University of Arizona | Klearchos Papas | Cures | 01-September-2023 to 31-August-2026 | $2,652,490.70 |
Evaluating the Initial Efficacy, Acceptability, and Feasibility of BFST-DT, an Intervention for Improving Transition Readiness for Adolescents and Emerging Adults with Type 1 Diabetes | Ann & Robert H. Lurie Children’s Hospital of Chicago | Jaclyn Papadakis | Improving Lives | 01-May-2023 to 30-April-2027 | $396,471.68 |
A hybrid effectiveness implementation trial of an intervention to reduce diabetes-specific emotional distress. | Ann & Robert H. Lurie Children’s Hospital of Chicago | Jill Weissberg-Benchell | Improving Lives | 01-September-2024 to 31-August-2029 | $1,936,551.00 |
Risk and Protective Factors for Optimal Health Outcomes in Children with Type 1 Diabetes (T1D) and their Parents | Ann & Robert H. Lurie Children’s Hospital of Chicago | Jillian Merrick | Transportfolio | 01-September-2023 to 31-August-2025 | $129,046.51 |
Telemedicine-Delivered Cognitive Behavioral Therapy to Reduce Diabetes Distress in Young Adults with Type 1 Diabetes (CBT-DD) | Albert Einstein College of Medicine | Jeffrey Gonzalez | Improving Lives | 01-September-2021 to 01-July-2027 | $1,484,824.00 |